Ovoca Bio | OVG - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 362.52M 357.69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
ALKERMES USD 20.89M 8.62M 2026-03
Avita Medical AUD 1.25M 100K 2025-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Ionis Pharmaceuticals USD 17M 1000K 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Moderna USD 11.49B 36B 2026-03
Organon & Co USD 111M 17M 2026-03
Ovoca Bio EUR 7K 6K 2022-06
Revvity USD 24.72M 1.2M 2026-03
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Viatris USD 120.1M 500K 2026-03
Xeris Pharmaceuticals USD 6.88M 269K 2026-03